Pleomorphic lobular carcinoma in situ of the breast composed almost entirely of signet ring cells

Pathology International

Volumn 56, Issue 11, 2006, Pages 683-687

  Fadare, Oluwole ^a,b  

^a WILFORD HALL MEDICAL CENTER   (United States)

^b Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

Breast; Pleomorphic lobular carcinoma in situ; Signet ring cells

Indexed keywords

ANTIBODY; CARMINIC ACID; CYTOKERATIN 20; CYTOKERATIN 7; EPIDERMAL GROWTH FACTOR RECEPTOR 2; KERATIN; MUCICARMINE; MUCIN 1; NEU DIFFERENTIATION FACTOR; PROGESTERONE RECEPTOR; UNCLASSIFIED DRUG; UVOMORULIN;

ADULT; ARTICLE; BREAST CARCINOMA; CARCINOMA IN SITU; CASE REPORT; CELL NUCLEUS; CELL PROLIFERATION; COMEDO; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREACTIVITY; INVASIVE CARCINOMA; LOBULAR CARCINOMA IN SITU; MITOSIS RATE; PATHOLOGY; PERIODIC ACID SCHIFF STAIN; PRIORITY JOURNAL; RARE DISEASE; SIGNET RING CARCINOMA; TUMOR CLASSIFICATION; TUMOR NECROSIS;

ADULT; ANTIGENS, NEOPLASM; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, LOBULAR; CARCINOMA, SIGNET RING CELL; CARMINE; CELL PROLIFERATION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINS; MUCIN-1; MUCINS; PERIODIC ACID-SCHIFF REACTION; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 33749987957     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2006.02030.x     Document Type: Article

References (24)

1. Saphir O. Mucinous carcinoma of the breast. Surg Gynecol Obstet 1941; 72: 908-14.
2. Steinbrecher JS, Silverberg SG. Signet-ring cell carcinoma of the breast. The mucinous variant of infiltrating lobular carcinoma? Cancer 1976; 37: 828-40.
3. Hull MT, Seo IS, Battersby JS, Csicsko JF. Signet-ring cell carcinoma of the breast: A clinicopathologic study of 24 cases. Am J Clin Pathol 1980; 73: 31-5.
4. Harris M, Wells S, Vasudev KS. Primary signet ring cell carcinoma of the breast. Histopathology 1978; 2: 171-6.
5. Al-Hariri JA. Primary signet ring cell carcinoma of the breast. Virchows Arch A Pathol Anat Histol 1980; 388: 105-11.
6. Izuishi K, Imoto S, Hasebe T. Signet ring cell carcinoma associated with invasive ductal carcinoma of the breast: A case report. Breast Cancer 1999; 6: 223-6.
7. Liu SM, Chen DR. Signet-ring cell carcinoma of the breast. Pathol Int 2000; 50: 67-70.
8. Merino MJ, Livolsi VA. Signet ring carcinoma of the female breast: A clinicopathologic analysis of 24 cases. Cancer 1981; 48: 1830-37.
9. Ermilova VD, Kuzina NK, Kuznetsova IS. Signet ring cell cancer of the breast. Arkh Patol 1985; 47: 59-62 (in Russian).
10. Eltorky M, Hall JC, Osborne PT, el Zeky F. Signet-ring cell variant of invasive lobular carcinoma of the breast. A clinicopathologic study of 11 cases. Arch Pathol Lab Med 1994; 118: 245-8.
11. Raju U, Ma CK, Shaw A. Signet ring variant of lobular carcinoma of the breast: A clinicopathologic and immunohistochemical study. Mod Pathol 1993; 6: 516-20.
12. Yoshida A, Hatanaka S, Oneda S, Yoshida H. Signet ring cells in breast carcinoma. An immunohistochemical and ultrastructural study. Acta Pathol Jpn 1992; 42: 523-8.
13. Frost AR, Terahata S, Yeh IT, Siegel RS, Overmoyer B, Silverberg SG. The significance of signet ring cells in infiltrating lobular carcinoma of the breast. Arch Pathol Lab Med 1995; 119: 64-8.
14. Ellis IO, Schnitt SJ, Sastre-Garau X et al. Invasive breast carcinoma. In: Tavassoli FA, Devilee P, eds. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Breast and Female Genital Organs. Lyon: IARC Press, 2003; 13-62.
15. Fisher ER, Brown R. Intraductal signet ring carcinoma. A hitherto undescribed form of intraductal carcinoma of the breast. Cancer 1985; 55: 2533-7.
16. Tavassoli FA. Infiltrating carcinoma: Common and familiar types. In: Tavassoli FA, ed. Pathology of the Breast, 2nd edn. New York, NY: McGraw-Hill, 1999; 401-80.
17. Bratthauer GL, Tavassoli FA. Lobular intraepithelial neoplasia: Previously unexplored aspects assessed in 775 cases and their clinical implications. Virchows Arch 2002; 440: 134-8.
18. Tavassoli FA. Lobular neoplasia. In: Tavassoli FA, ed. Pathology of the Breast, 2nd edn. New York, NY: McGraw-Hill, 1999; 373-400.
19. Frost AR, Tsangaris TN, Silverberg SG. Pleomorphic lobular carcinoma in situ. Pathol Case Rev 1996; 1: 27-31.
20. Middleton LP, Palacios DM, Bryant BR, Krebs P, Otis CN, Merino MJ. Pleomorphic lobular carcinoma: Morphology, immunohistochemistry, and molecular analysis. Am J Surg Pathol 2000; 24: 1650-56.
21. Fulford LG, Reis-Filho JS, Lakhani SR. Lobular in situ neoplasia. Curr Diagn Pathol 2004; 10: 183-92.
22. Bratthauer GL, Moinfar F, Stamatakos MD et al. Combined E-cadherin and high molecular weight cytokeratin immunoprofile differentiates lobular, ductal, and hybrid mammary intraepithelial neoplasias. Hum Pathol 2002; 33: 620-27.
23. Moinfar F, Man YG, Lininger RA, Bodian C, Tavassoli FA. Use of keratin 35betaE12 as an adjunct in the diagnosis of mammary intraepithelial neoplasia-ductal type: Benign and malignant intraductal proliferations. Am J Surg Pathol 1999; 23: 1048-58.
24. Chu PG, Weiss LM. Immunohistochemical characterization of signet-ring cell carcinomas of the stomach, breast, and colon. Am J Clin Pathol 2004; 121: 884-92.